ArticleExperimental and therapeutic medicine2022

Pathological complete response following cisplatin or carboplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: A systematic review and meta-analysis.

Radu Vidra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.